TriangleNivolumab (NCT05647265)
Nivolumab trial for Pleural Biphasic Mesothelioma (NCT05647265). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with untreated stage I–IIIA pleural mesothelioma that is sarcomatoid or more than half sarcomatoid in a mixed tumor. Patients must be surgical candidates.
The idea: intravenous nivolumab and ipilimumab aim to help the immune system attack cancer before surgery. Surgery depends on fitness, lung function, side effects, and absence of progression that prevents removal. Researchers measure how many patients reach surgery and remain free of progression at twelve months.
This phase 2 study plans 26 patients. Alliance for Clinical Trials in Oncology sponsors it; 104 US locations recruit.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.